Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 0	$ 125,280	$ 0	$ 263,006
General and administrative	199,991	48,816	907,684	166,910
Total operating expenses	199,991	174,096	907,684	429,916
Loss from operations	(199,991)	(174,096)	(907,684)	(429,916)
Other income (expense):
Interest expense	(440)	(805)	(1,147)	(2,420)
Other income	453	45	1,989	317
Total other income (expense)	13	(760)	842	(2,103)
Net loss	(199,978)	(174,856)	(906,842)	(432,019)
Noncontrolling interest	(8,033)	0	(9,275)	0
Net loss attributable to Healthcare Business Resources, Inc.	$ (191,945)	$ (174,856)	$ (897,567)	$ (432,019)
Loss per share - basic and diluted attributable to Health Business Resources, Inc.	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Loss per share - basic and diluted attributable to noncontrolling interest.	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average shares outstanding - basic and diluted	1,054,150,003	993,399,680	1,047,562,344	985,423,478